Navigation Links
deCODE genetics Announces Third Quarter 2008 Financial Results
Date:11/6/2008

, as well as $5.5 million in restricted investments in U.S. Treasury Bills and $18.2 million in illiquid, non-current investments in auction rate securities. At December 31, 2007, the company had $94.1 million in cash, cash equivalents, restricted cash equivalents, and investments.

The company is undertaking a review of its long-term business strategy with the goal of sharpening the focus of its business, selling assets, securing partnerships, and utilizing the resources generated to support product development and marketing efforts in its core business. The company has utilized a 30-day grace period for the scheduled October 15 interest payment on its 3.5% Senior Convertible Notes due 2011 and is reviewing methods for making this payment. Given its current liquid assets, and without paying the interest on its Notes from its present funds, the company must obtain further financial resources through either the implementation of strategic alternatives, corporate partnerships, or the sale of or loans secured by its auction rate securities in order to continue operations beyond the end of this year. The company is focused on reducing expenses and speeding the evaluation of its strategic options in order to obtain the resources to do so.

deCODE has significant operations in Iceland and pays a large proportion of its fixed costs in Icelandic krona, while its sales are generally denominated in US dollars and its reporting currency is the US dollar. During the third quarter and beginning of the fourth quarter the global financial crisis caused significant economic turmoil in Iceland. As a result, the value of the Icelandic krona has declined significantly versus the US dollar. The turmoil in the Icelandic financial sector and economy as a whole have not to date had any significant adverse impact on deCODE or its day to day operations. deCODE is monitoring closely the situation in Iceland, the principal impact of which for the company has been to decrease the d
'/>"/>

SOURCE deCODE genetics Inc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
2. deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2007 Financial Results
3. deCODE genetics Announces Third Quarter 2007 Financial Results
4. deCODE Launches deCODEme(TM)
5. deCODE genetics to Webcast Presentation at JPMorgan Annual Healthcare Conference
6. deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women
7. deCODE genetics to Webcast Presentation at BIO CEO and Investor Conference
8. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
9. deCODE Genetics Announces Full-year 2007 Financial Results
10. deCODE genetics to Webcast Presentation at Lehman Brothers Eleventh Annual Global Healthcare Conference
11. deCODE genetics to Webcast Presentation at 15th Annual Future Leaders in the Biotech Industry Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... energy costs continue to soar, renewable sources ...n attractive replacement for gasoline is biofuel, ...earch ( www.genome.org ), scientists have analyze...croorganisms, uncovering genetic clues that will b...o implement production on a global scale. , Bioe...
(Date:11/6/2009)... Microbix Biosystems Inc. (the "Company") announce...tification of Annual Filings of William Gastle, th...f Financial Officer (the "Officer,s Certificates")...ual audited financial statements for the year ende...filed the annual financial statements for the year...
(Date:11/6/2009)...riant Technologies LLC ("Myriant"), a privately-he...le bio-chemicals, Uhde Corporation of America and ...f the world,s leading engineering contractors (joi...ering, procurement & construction (EPC) of Myr...wable feedstocks. The execution of this alliance ...
(Date:11/6/2009)...e/ -- Calbiotech, Inc. announced today that it has... (SBIR) Phase I contract by the U.S. Army Medical ...agreement, Calbiotech will develop analyte specifi...s. ,, Dengue virus is a mosquito-born flaviv...rces deployed to tropical areas of the world. Due ...
Breaking Biology Technology:Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2
...sdaq: SUPG ), a pharmaceutical company dedicated ...herapies, today announced that it will release,its...November 4, 2008.,SuperGen,s management team will ... and any revised outlook for the future., A press...ediately,following the close of the market on Nove...
...6th Annual Meeting -, PRINCETON, N.J. and ANNAPOL...a leading monoclonal antibody company, and,PharmAt...eloping medical,countermeasures against biological...m a pilot study showing that the anthrax anti-toxi...mpared to a control group in a,therapeutic animal ...
... global demand for health economi...ston Healthcare Associates, Inc.,today announced t...Mr. Barak brings 16 years of pricing and reimburse...l pricing and reimbursement strategies,for drugs, ...f therapeutic,areas including oncology, pulmonary ...
Other Biology Technology:SuperGen to Announce 2008 Third Quarter Financial Results November 4, 2008 2Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 2Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 3Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 4Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 5Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 6Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 7Boston Healthcare Appoints Adam Barak as Vice President Enhancing Its International Pricing and Reimbursement Capability 2
(Date:11/4/2009)..., LEADS: (top news in natural science) , Uni...States uses less water today than it did 35 years ...lines in water use are partly attributable to alte...fficient irrigation systems. According to the late... used in the United States goes to cooling thermoe...
(Date:11/4/2009)... St. Louis, MO, November 4, 2009 Childhood obesit...tions. With more than one fourth of advertising on...s and beverages and continuing questions about the...November/December issue of the Journal of Nutriti...tising aimed at children might be a large contribu...
(Date:11/4/2009)... The Singapore laboratory that deciphered the DNA ...h) and elephant shark, has joined The Genome 10K P...able repository of DNA sequences on 10,000 species...a scale that currently can not be achieved. , Pa...n a paper published in the Nov. 5, 2009 issue of t...
Breaking Biology News(10 mins):USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Singapore scientists join international study of 10,000 vertebrates' genomes 2GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with 55880 1GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with 55880 2GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with 55880 3GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with 55880 4Saving Lives Is a Growth Industry 55875 1Saving Lives Is a Growth Industry 55875 2Saving Lives Is a Growth Industry 55875 3Expanded insurance benefits break down barriers to hospice care according to new study 55872 1Expanded insurance benefits break down barriers to hospice care according to new study 55872 2
... Virginia (Dec. 11, 2007) A quick and cool way to...ww.conservation.org/carboncalculator . , Lively v...tion Internationals (CI) new online carbon calcula...they are adding to global greenhouse gases. The C...missions by helping protect tropical forests from ...
...ING, Mich. Michigan State Universitys panda habit...ins of data aimed at understanding and saving gian...ch crucial data thats black, white and furry. , V...y, remote mountains of the Sichuan Province of Chi... hoping to capture, collar and track up to four wi...
...I, DECEMBER 10, 2007 Scientists at Punjab Agricult...nstitute, and Virginia Tech have been successful i...a using site-specific nutrient management strategi...percent of the Indian rice production, is currentl... as compared to the yield growth rate during the g...
Other Biology News:New carbon calculator conserves forests 2To catch a panda 2Researchers combat slowing yields with targeted fertilizer applications 2
Rabbit Anti-ICAD / DFF45 (NT) Polyclonal Antibody, Unconjugated from ProSci, Inc
Rabbit Anti-Human ZFP91 Polyclonal Antibody, Unconjugated from Abcam
Anti-AANAT Antibody, Unconjugated from CHEMICON
Rat Anti-B7 RP1 Monoclonal Antibody, Phycoerythrin Conjugated, Clone HK5.3 from Abcam
Biology Products: